Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.
Stay updated with breaking news from Manmeet Soni. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.
Summit Therapeutics Inc. today announced that it will participate in and present at the Stifel 2024 Targeted Oncology Forum, which will be held virtually April 16-17, 2024. Dr. Maky Zanganeh, Chief...
Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. All participants will be able to listen only until the question-and-answer portion of this call. We do not expect any technical difficulties today; however, in the event […]
Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.
In a significant move, Manmeet Soni, the Chief Operating Officer (COO) of Summit Therapeutics Inc (NASDAQ:SMMT), purchased 2,976,190 shares of the company on October 13, 2023.